Phase 2, Multiple Ascending Dose Proof of Concept Study
Clinical trial NCT02710604 · COMPLETED
Trial details
- NCT number
- NCT02710604
- Sponsor
- ContraVir Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-07-18
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.